Accelerating Medical Radioisotope Production

Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher, Terry Grimm, and a group of private investors. Niowave is a worldwide leader in the research, development, manufacturing, and operation of superconducting electron linear accelerators which are used for medical radioisotope production.

Core Competencies

Niowave’s isotope production is unique due to the following core competencies:

  • Niowave is the only company in the world that can build and operate superconducting electron accelerators

  • Niowave is licensed by the NRC to work with radioactive materials, including uranium

  • Niowave operates an in-house radiochemistry facility to extract and purify solid, liquid, and gaseous radioactive isotopes